Latest Insider Transactions at Royalty Pharma PLC (RPRX)
This section provides a real-time view of insider transactions for Royalty Pharma PLC (RPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Royalty Pharma plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Royalty Pharma plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
75,000
-11.23%
|
$3,000,000
$40.0 P/Share
|
|
Dec 28
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
109,448
-6.97%
|
$4,377,920
$40.21 P/Share
|
|
Dec 28
2021
|
Rory B Riggs Director |
SELL
Other acquisition or disposition
|
Indirect |
1,265,552
-34.97%
|
-
|
|
Dec 28
2021
|
Rory B Riggs Director |
BUY
Other acquisition or disposition
|
Direct |
45,350
+3.22%
|
-
|
|
Nov 17
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
139,389
-5.65%
|
$5,854,338
$42.34 P/Share
|
|
Nov 17
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
62,435
-9.12%
|
$2,622,270
$42.39 P/Share
|
|
Nov 17
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
84,148
-11.78%
|
$3,534,216
$42.39 P/Share
|
|
Nov 16
2021
|
Rory B Riggs Director |
SELL
Other acquisition or disposition
|
Indirect |
1,861,351
-32.64%
|
-
|
|
Nov 16
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
12,565
-1.8%
|
$527,730
$42.01 P/Share
|
|
Nov 16
2021
|
Rory B Riggs Director |
BUY
Other acquisition or disposition
|
Direct |
66,012
+4.41%
|
-
|
|
Nov 16
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
165,852
-8.62%
|
$6,965,784
$42.55 P/Share
|
|
Sep 30
2021
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
992
+4.17%
|
$36,704
$37.8 P/Share
|
|
Sep 30
2021
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
992
+5.52%
|
$36,704
$37.8 P/Share
|
|
Sep 29
2021
|
Rory B Riggs Director |
SELL
Other acquisition or disposition
|
Indirect |
936,427
-14.1%
|
-
|
|
Sep 29
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
63,777
-1.56%
|
$2,295,972
$36.43 P/Share
|
|
Sep 29
2021
|
Rory B Riggs Director |
BUY
Other acquisition or disposition
|
Direct |
16,274
+0.86%
|
-
|
|
Sep 29
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
24,648
-3.85%
|
$887,328
$36.5 P/Share
|
|
Sep 28
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
40,000
-5.88%
|
$1,440,000
$36.75 P/Share
|
|
Jul 26
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
17,898
-0.76%
|
$698,022
$39.78 P/Share
|
|
Jul 26
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
13,362
-0.94%
|
$521,118
$39.79 P/Share
|
|
Jul 14
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2
-0.0%
|
$84
$42.0 P/Share
|
|
Jul 13
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
17,832
-1.49%
|
$748,944
$42.01 P/Share
|
|
Jul 13
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
23,049
-1.53%
|
$968,058
$42.01 P/Share
|
|
Jul 12
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
100
-0.01%
|
$4,200
$42.04 P/Share
|
|
Jul 12
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
100
-0.01%
|
$4,200
$42.04 P/Share
|
|
Jul 08
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
49,059
-3.08%
|
$2,060,478
$42.05 P/Share
|
|
Jul 08
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
40,655
-3.28%
|
$1,707,510
$42.05 P/Share
|
|
Jul 07
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
2,900
-0.18%
|
$121,800
$42.01 P/Share
|
|
Jul 07
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2,192
-0.18%
|
$92,064
$42.01 P/Share
|
|
Jul 06
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
36,530
-2.22%
|
$1,534,260
$42.41 P/Share
|
|
Jul 06
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
30,270
-2.38%
|
$1,271,340
$42.4 P/Share
|
|
Jun 30
2021
|
William E Ford Director |
BUY
Grant, award, or other acquisition
|
Direct |
871
+11.66%
|
$37,453
$43.04 P/Share
|
|
Jun 30
2021
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
871
+3.85%
|
$37,453
$43.04 P/Share
|
|
Jun 30
2021
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
871
+5.17%
|
$37,453
$43.04 P/Share
|
|
Jun 29
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
481,000
-6.12%
|
$19,721,000
$41.63 P/Share
|
|
Jun 28
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
167,448
-4.08%
|
$7,032,816
$42.11 P/Share
|
|
Jun 25
2021
|
Catherine M. Engelbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,726
+23.03%
|
-
|
|
Jun 25
2021
|
Gregory Norden Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,726
+10.21%
|
-
|
|
Jun 25
2021
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,726
+27.47%
|
-
|
|
Jun 25
2021
|
William E Ford Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,726
+50.0%
|
-
|
|
Jun 25
2021
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,726
+21.5%
|
-
|
|
Jun 25
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
666,464
-13.36%
|
$27,991,488
$42.75 P/Share
|
|
Jun 25
2021
|
Errol B Desouza Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,726
+10.21%
|
-
|
|
Jun 25
2021
|
Ted W Love Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,726
+20.03%
|
-
|
|
Jun 10
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
70,000
-3.82%
|
$3,220,000
$46.48 P/Share
|
|
Jun 08
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-3.79%
|
$2,300,000
$46.43 P/Share
|
|
Jun 08
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
70,000
-3.68%
|
$3,220,000
$46.48 P/Share
|
|
Jun 07
2021
|
Rory B Riggs Director |
BUY
Open market or private sale
|
Indirect |
273,650
+11.62%
|
$12,314,250
$45.26 P/Share
|
|
Jun 07
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-1.83%
|
$2,300,000
$46.79 P/Share
|
|
Jun 07
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
122,500
-3.15%
|
$5,635,000
$46.34 P/Share
|